Arizona Center for Cancer Care

Surprise, Arizona 85374

0 studies enrolling now · 2 studies all time

What they study most

First Line Non-Small Cell Lung Cancer, Metastatic Breast Cancer

Studies at this site

• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed